4//SEC Filing
Helsel Dave 4
Accession 0001140361-23-036321
CIK 0001275187other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:32 PM ET
Size
8.9 KB
Accession
0001140361-23-036321
Insider Transaction Report
Form 4
Helsel Dave
SVP Global Operations and R&D
Transactions
- Exercise/Conversion
Common Stock
2023-07-19+4,371→ 32,660 total - Tax Payment
Common Stock
2023-07-19$8.92/sh−1,575$14,049→ 31,085 total - Exercise/Conversion
Performance Right
2023-07-19−15,081→ 0 total→ Common Stock (15,081 underlying)
Footnotes (3)
- [F1]This acquisition of 4,371 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020.
- [F2]The exempt disposition of 1,575 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020.
- [F3]On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001543753
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:32 PM ET
- Size
- 8.9 KB